Ngā hua rapu - Judith de Vos‐Geelen
- E whakaatu ana i te 1 - 20 hua o te 29
- Haere ki te Whārangi Whai Ake
-
1
-
2
Cervical esophageal cancer: a gap in cancer knowledge mā Ann Hoeben, J Polák, Lien Van De Voorde, Frank Hoebers, Heike I. Grabsch, Judith de Vos‐Geelen
I whakaputaina 2016Revisão -
3
Feasibility and preliminary effectiveness of a physical exercise training program during neoadjuvant chemoradiotherapy in individual patients with rectal cancer prior to major elec... mā A.F.J.M. Heldens, Bart C. Bongers, Judith de Vos‐Geelen, N.L.U. van Meeteren, Antoine F. Lenssen
I whakaputaina 2016Artigo -
4
Multicenter randomized controlled trial to evaluate the efficacy and tolerability of frozen gloves for the prevention of chemotherapy-induced peripheral neuropathy mā Antoinetta J. M. Beijers, Cynthia S. Bonhof, Floortje Mols, J. Ophorst, Judith de Vos‐Geelen, E Jacobs, Lonneke V. van de Poll‐Franse, Gerard Vreugdenhil
I whakaputaina 2020Artigo -
5
Recurrence after preoperative chemotherapy and surgery for gastric adenocarcinoma: a multicenter study mā I. Mokadem, Willemieke P.M. Dijksterhuis, Margreet van Putten, Lianne Heuthorst, Judith de Vos‐Geelen, Nadia Haj Mohammad, Grard A. P. Nieuwenhuijzen, Hanneke W.M. van Laarhoven, Rob H.A. Verhoeven
I whakaputaina 2019Artigo -
6
Patient- and tumor-related predictors of chemotherapy intolerance in older patients with cancer: A systematic review mā Doris L. van Abbema, Marjan van den Akker, Maryska L.G. Janssen‐Heijnen, Franchette van den Berkmortel, Ann Hoeben, Judith de Vos‐Geelen, Frank Buntinx, Jos Kleijnen, Vivianne C. G. Tjan‐Heijnen
I whakaputaina 2018Revisão -
7
Efficacy and safety of FOLFIRINOX as salvage treatment in advanced biliary tract cancer: an open-label, single arm, phase 2 trial mā Ali Belkouz, Judith de Vos‐Geelen, Ron A. A. Mathôt, Ferry A.L.M. Eskens, Thomas M. van Gulik, Martijn G.H. van Oijen, Cornelis J.A. Punt, Johanna W. Wilmink, Heinz‐Josef Klümpen
I whakaputaina 2020Artigo -
8
The gut microbiota during tamoxifen therapy in patients with breast cancer mā Lars E. Hillege, David Barnett, Janine Ziemons, Romy Aarnoutse, Judith de Vos‐Geelen, Robin M.J.M. van Geel, Maaike de Boer, Yvonne E A van Riet, Jeroen Vincent, John Penders, Marjolein L. Smidt
I whakaputaina 2025Artigo -
9
Functional status decline in older patients with breast and colorectal cancer after cancer treatment: A prospective cohort study mā Doris van Abbema, Arnée van Vuuren, Franchette van den Berkmortel, Marjan van den Akker, Laura Deckx, Frank Buntinx, Roel van Kampen, Els Lambooij, Maaike de Boer, Judith de Vos‐Geelen, Vivianne C. G. Tjan‐Heijnen
I whakaputaina 2017Artigo -
10
Heterogeneity of first‐line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real‐world evidence study mā Willemieke P.M. Dijksterhuis, Rob H.A. Verhoeven, Marije Slingerland, Nadia Haj Mohammad, Judith de Vos‐Geelen, Laurens V. Beerepoot, Theo van Voorthuizen, Geert‐Jan Creemers, Martijn G.H. van Oijen, Hanneke W.M. van Laarhoven
I whakaputaina 2019Artigo -
11
Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy mā Romy Aarnoutse, Janine Ziemons, Lars E. Hillege, Judith de Vos‐Geelen, Maaike de Boer, Saskia M. P. Bisschop, Birgit E. P. J. Vriens, Jeroen Vincent, Agnès J. van de Wouw, Ngoc Giang Le, Koen Venema, Sander S. Rensen, John Penders, Marjolein L. Smidt
I whakaputaina 2022Artigo -
12
Effect of Itraconazole and Rifampin on the Pharmacokinetics of Olaparib in Patients With Advanced Solid Tumors: Results of Two Phase I Open-label Studies mā Luc Dirix, Helen Swaisland, Henk M.W. Verheul, Sylvie Rottey, Karin Leunen, Guy Jérusalem, Christian Rolfo, Dorte Nielsen, L. Rhoda Molife, Rebecca Kristeleit, Judith de Vos‐Geelen, Morten Mau‐Sørensen, Patricia M.M.B. Soetekouw, Carla van Herpen, Anitra Fielding, Karen So, Wendy Bannister, Ruth Plummer
I whakaputaina 2016Artigo -
13
Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study mā Marin Strijker, Ali Belkouz, Lydia G. van der Geest, Thomas M. van Gulik, Jeanin E. van Hooft, Vincent E. de Meijer, Nadia Haj Mohammad, Philip R. de Reuver, Joanne Verheij, Judith de Vos‐Geelen, Johanna W. Wilmink, Bas Groot Koerkamp, Heinz‐Josef Klümpen, Marc G. Besselink
I whakaputaina 2019Artigo -
14
Practical cancer nutrition, from guidelines to clinical practice: a digital solution to patient-centred care mā Kristin S. Hustad, Lisa Heide Koteng, Amaia Urrizola, Jann Arends, Asta Bye, Olav Dajani, Luc Deliëns, Marie Fallon, Marianne Jensen Hjermstad, Maxime Kohlen, Geana Paula Kurita, Tonje Lundeby, Nicoleta Mitrea, Cathy Payne, Susana Roselló‐Keränen, N.S. Warmbrodt, Annie wilde, S. Kaasa, Judith de Vos‐Geelen, B J A Laird
I whakaputaina 2025Artigo -
15
Association of the location of pancreatic ductal adenocarcinoma (head, body, tail) with tumor stage, treatment, and survival: a population-based analysis mā Felice N. van Erning, Tara M. Mackay, Lydia G. van der Geest, Bas Groot Koerkamp, Hanneke W.M. van Laarhoven, Bert A. Bonsing, Johanna W. Wilmink, Hjalmar C. van Santvoort, Judith de Vos‐Geelen, Casper H.J. van Eijck, Olivier R. Busch, V.E.P.P. Lemmens, Marc G. Besselink
I whakaputaina 2018Artigo -
16
Surgical Complications in a Multicenter Randomized Trial Comparing Preoperative Chemoradiotherapy and Immediate Surgery in Patients With Resectable and Borderline Resectable Pancre... mā Jelle C. van Dongen, Mustafa Suker, Eva Versteijne, Bert A. Bonsing, J. Sven D. Mieog, Judith de Vos‐Geelen, Erwin van der Harst, Gijs A. Patijn, Ignace H. J. T. de Hingh, Sebastiaan Festen, Albert J. ten Tije, Olivier R. Busch, Marc G. Besselink, Geertjan van Tienhoven, Bas Groot Koerkamp, Casper H.J. van Eijck
I whakaputaina 2020Artigo -
17
Nerve fibers in the tumor microenvironment in neurotropic cancer—pancreatic cancer and cholangiocarcinoma mā Xiuxiang Tan, Shivan Sivakumar, Jan Bednarsch, Georg Wiltberger, Jakob Nikolas Kather, J. Niehues, Judith de Vos‐Geelen, Liselot Valkenburg‐van Iersel, Svetlana Kintsler, Anjali A. Roeth, Guangshan Hao, Sven Arke Lang, Mariëlle Coolsen, Marcel den Dulk, Merel R. Aberle, Jarne Koolen, Nadine T. Gaisa, Steven W.M. Olde Damink, Ulf P. Neumann, Lara R. Heij
I whakaputaina 2020Revisão -
18
Stroma and lymphocytes identified by deep learning are independent predictors for survival in pancreatic cancer mā Xiuxiang Tan, Mika Rosin, Simone Appinger, Julia Campello Deierl, Konrad Reichel, Mariëlle Coolsen, Liselot Valkenburg‐van Iersel, Judith de Vos‐Geelen, Evelien J.M. de Jong, Jan Bednarsch, Bas Groot Koerkamp, Michail Doukas, Casper W.F. van Eijck, Tom Luedde, Edgar Dahl, Jakob Nikolas Kather, Shivan Sivakumar, Wolfram Trudo Knoefel, Georg Wiltberger, Ulf Neumann, Lara R. Heij
I whakaputaina 2025Artigo -
19
Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma mā Anouk E.J. Latenstein, Lydia G. van der Geest, Bert A. Bonsing, Bas Groot Koerkamp, Nadia Haj Mohammad, Ignace H. J. T. de Hingh, Vincent E. de Meijer, I. Quintus Molenaar, Hjalmar C. van Santvoort, Geertjan van Tienhoven, Joanne Verheij, Pauline A. J. Vissers, Judith de Vos‐Geelen, Olivier R. Busch, Casper H.J. van Eijck, Hanneke W.M. van Laarhoven, Marc G. Besselink, Johanna W. Wilmink
I whakaputaina 2019Artigo -
20
Transarterial Chemoembolization With Drug-Eluting Beads Versus Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Outcomes From a Multicenter, Randomized, Phase 2 Tr... mā Alejandra Méndez Romero, Bronno van der Holt, François E.J.A. Willemssen, Rob A. de Man, Ben Heijmen, Steven Habraken, Henrike Westerveld, Otto M. van Delden, Heinz‐Josef Klümpen, Eric T.T.L. Tjwa, Pètra M. Braam, Sjoerd F.M. Jenniskens, Thomas Vanwolleghem, Reinhilde Weytjens, O d'Archambeau, Judith de Vos‐Geelen, Jeroen Buijsen, Christiaan van der Leij, Wilhelm den Toom, Dave Sprengers, Jan N.M. IJzermans, Adriaan Moelker
I whakaputaina 2023Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Internal medicine
Cancer
Oncology
Chemotherapy
Pancreatic cancer
Surgery
Breast cancer
Adenocarcinoma
Colorectal cancer
Randomized controlled trial
Gemcitabine
Biology
Chemoradiotherapy
Pathology
Radiation therapy
Cancer registry
Clinical endpoint
Cohort
Confidence interval
Environmental health
Hazard ratio
Immunology
Neoadjuvant therapy
Nursing
Oxaliplatin
Population
Adverse effect
Bioinformatics
Gastroenterology